Clinical and regulatory intelligence for Substance Use Disorders with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Assets: 1

Relevant assets

RCT →

Relevant companies

No related entities indexed yet.

Recent signals(3)

ClinicalAugust 1, 2026

RCT to Evaluate Outpatient Treatment for Adolescents with Substance Use and Internalizing Disorders

A randomized clinical trial will compare a new psychosocial treatment for adolescents with co-occurring substance use and internalizing disorders against an active placebo.

ClinicalJuly 21, 2026

Study on Dopamine Release in Cocaine Use Disorders Using PET Imaging

This study investigates dopamine release in cocaine use disorders using PET imaging with amphetamine challenges.

Clinical

June 30, 2026

Study on App-Based Incentives for Older Adults with Substance Use Disorders

A study is assessing the effectiveness of app-based incentives for older adults with substance use disorders, comparing their engagement and efficacy to younger adults.

Upcoming catalysts

No catalysts indexed for this entity yet.

Therapeutic areas

Addiction →

Neurology →

Psychiatry →

Substance Use Disorders →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.